National Framework Agreement for the Supply of Immunoglobulin
key details
| Value | £749,380,980 |
|---|---|
| Status | complete |
| Category (CPV) | 33651520 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 28 Apr 2017 |
| Contract start | 1 Jul 2017 |
| Contract end | 30 Jun 2019 |
| Procedure | open |
| SME suitable | No |
| OCID | ocds-b5fd17-ec885de3-32e2-4f16-81c1-f09afc8f7a86 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please refer to word doc called Awarded Suppliers Name | £187,345,245 | 15 Jun 2017 | active |
description
National Framework Agreement for the Supply of Immunoglobulin
Offer reference number: CM/PHS/13/5404
Period of framework agreement: 1st July 2017 to 30th June 2018 with options to extend up to a further 36 months
Additional information: National Framework Agreement for the Supply of Immunoglobulin Award Documents
documents
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/d4553dcd-27c3-47fc-8516-8fcfb5535220 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/f5fe8888-5f4c-43e0-9207-14d7c626f8be , tenderNotice
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 17 Aug 2018 | Award update (awardUpdate) | · | 713a33fd-f076-4db4-ae04-bbdbb254ca3d-235698 |
more from COMMERCIAL MEDICINES UNIT
- NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumables · £22,000,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Recombinant Factor IX products for the treatment of bleeding disorders · £50,600,000 · 17 Aug 2018
- NHS National Framework Agreement for the supply of Human Cell Line Recombinant Factor VIII products · £4,125,000 · 17 Aug 2018
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin · £19,539,253 · 23 Dec 2016
- Contract for the supply of rotavirus vaccine · 22 Dec 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin · NHS England · £1,200,000,000
- NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin · NHS ENGLAND
- SUPPLY OF BOTULISM ANTITOXIN HEPTEVALENT (HBAT) · Ministry of Defence
- SARS-CoV-2 Nucleocapsid proteins for LFT Revalidation and Testing · UK Health Security Agency · £500,000
- CMU Framework for the supply of Anti-D Immunoglobulin · University Hospitals of Leicester NHS Trust · £209,801
- PHE_Scientific Provision for purchase of the Euroimmun Anti SARS CoV 2 IgG assay · Public Health England · £158,400
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) · The NHS Commissioning Board (operating under the name of NHS England)
- 1LHE Goods - Antibodies · NEWCASTLE UNIVERSITY · £25,115
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.